LabCorp Announces 2020 First Quarter Results

Q1 revenue of $2.82 billion , up 1% over $2.79 billion last year Q1 diluted EPS of ( $3.27 ), which include goodwill and other asset impairments of $4.43 per share Q1 adjusted EPS of $2.37 , which were negatively impacted by an estimated $0.55 per share from the COVID-19 pandemic Q1 free cash flow

Ruth Heim, PhD, FACMG

Dr Heim is currently a diplomate of the American Board of Medical Genetics and Genomics and a fellow of the American College of Medical Genetics. She is certified by the New York State Department of Health as a director of genetic testing (molecular) and molecular and cellular tumor markers. Dr Heim graduated from the University of the Witwatersrand, South Africa, with a First Class BSc(Hons) degree and a PhD in human molecular genetics. She completed postdoctoral fellowship training in clinical molecular genetics at the University of North Carolina Chapel Hill.

Walgreens to further expand COVID-19 testing with plans to open drive-thru locations in 49 U.S. States and Puerto Rico

Labcorp stands ready to serve COVID-19 testing needs with increased capacity, multiple testing options and ways to access testing, and no up-front out-of-pocket costs